Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites
11 Juli 2023 - 1:09PM
Velocity Clinical Research (“Velocity”), the leading
multi-specialty clinical sites business, and Privia Health
(Nasdaq: PRVA), a physician enablement company serving more than
3,700 providers and 4.4 million patients, today announced a
partnership to open embedded clinical research sites within
Privia’s practice network.
The partnership is intended to establish integrated research
sites within existing Privia Care Center locations that do not
currently conduct clinical trials. Velocity will staff and operate
the joint research sites, bringing management experience in
clinical trial operations and patient recruitment.
The first of these sites is in West Texas Health, a clinic in
Abilene, Texas, led by Thomas Headstream, MD. The site, located in
a medical mall with specialty clinics, will bring research
opportunities to Abilene’s diverse community.
Keith Fernandez, MD, Privia Health Chief Clinical
Officer, said, “The Privia Clinical Research program
supports our Company’s mission to provide great care to patients
and lighten the administrative burden for physicians and their
practices. Velocity has an excellent reputation, and we look
forward to gaining the benefits of this partnership.”
The partnership gives Velocity access to a large, integrated
network of multi-specialty providers, which will expand its
therapeutic base in specialty care and increase the number of
physicians becoming Principal Investigators at a time when there is
a chronic long-term decline in investigator numbers.
Paul Evans, PhD, Velocity President and Chief Executive
Officer, added: “Velocity has the people and Privia has
the coverage. By bringing professional management of clinical
trials to specialty care, we are opening up research opportunities
for more patients. Through an embedded model, Privia benefits from
increased activity at their clinics and Velocity has the
opportunity to move into new therapeutic areas. We expect to see
more partnerships of this kind, as the clinical trials landscape
matures and achieves the scale to work with established
organizations, like Privia.”
Velocity’s acquisition of Meridian Clinical Research in December
2022 accelerated its move into specialty care through an embedded
site model strategy. As part of its own growth, Meridian pioneered
a site model that focused on establishing dedicated research
facilities in clinical practices. Velocity will continue to expand
on this model and leverage it through strategic partnerships.
About Velocity Clinical Research
Velocity is the leading integrated site organization for
clinical trials. With 80 sites and more than 220 investigators,
Velocity partners with pharmaceutical and biotechnology companies
to research new drugs, medical devices, diagnostics, and
combination products that could improve human health and wellbeing.
Velocity offers unified research site solutions to efficiently
provide the right patients, investigators, and research staff for
clinical trials across the U.S. and Europe. The company also
operates a technology hub in India, where it is unlocking a new era
in clinical research by developing innovative systems to leverage
expansive site, patient, and historical performance data. To learn
more about how Velocity delivers high-quality data, exemplary
patient care, and unprecedented efficiency for clinical trials at
any scale, visit VelocityClinical.com.
About Privia Health
Privia Health™ is a technology-driven, national physician
enablement company that collaborates with medical groups, health
plans, and health systems to optimize physician practices, improve
patient experiences, and reward doctors for delivering high-value
care in both in-person and virtual settings. The Privia Platform is
led by top industry talent and exceptional physician leadership,
and consists of scalable operations and end-to-end, cloud-based
technology that reduces unnecessary healthcare costs, achieves
better outcomes, and improves the health of patients and the
well-being of providers. For more information,
visit priviahealth.com.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/eb28e27e-5a24-4fb5-ac5d-c2a4c2c614e5
Contact:
Katie Evans
kevans@velocityclinical.com
Privia Health (NASDAQ:PRVA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Privia Health (NASDAQ:PRVA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024